NEW YORK, Oct. 20 /PRNewswire-FirstCall/ -- Sanders Morris Harris Investment Banking, a division of Sanders Morris Harris Inc., member NASD/SIPC, is hosting its second annual middle market investor growth conference in New York at the Omni Berkshire Hotel on October 23rd and 24th. The firm specifically designed this year’s event for alternative, institutional, middle market, and private equity investors, as well as independent research analysts. Featured keynote speaker on Tuesday, October 24th is William Haseltine, PhD, Chairman, Haseltine Global Health LLC, who will share his views on the restructuring of the biopharmaceutical industry, specifically addressing the “productivity crises.” Introducing Dr. Haseltine, will be Peter Mixter, Sanders Morris Harris Healthcare Investment Banking Group. Mr. Mixter observes that Dr. Haseltine brings together a unique perspective from his diverse background as a distinguished research scientist and well-recognized clinician while at Harvard Medical School and as a successful businessman having founded and built multiple biopharmaceutical companies, one of which, Human Genome Sciences, used breakthrough technology to pioneer novel ways of studying disease and discovering new drugs.
Approximately 80 companies are expected to present at the 2006 conference. Presenting companies represent a diverse group of industries, market capitalization, and investment styles (growth vs. value). With respect to the new healthcare practice at Sanders Morris Harris, based out of the New York Office, we are pleased that both Teva Pharmaceutical Industries Ltd. , TEVA (NASDAQ) and Crucell, CRXL (ENXTAM) will be presenting at the 2006 conference.
Additional presenters include: Biotechnology: Cytomedix, Inc., GTF (AMEX); Dyadic International, Inc., DIL (AMEX) Distributors: Familymeds Group, Inc., FMRX (NASDAQ) Managed Care: Metropolitan Health Networks Inc., MDF (AMEX) Pharmaceutical Services: etrials Worldwide, Inc., ETWC (NASDAQ) Specialty Pharmaceutical: Valera Pharmaceuticals, Inc., VLRX (NASDAQ) Medical Supplies: Bioject Medical Technologies, Inc., BJCT (NASDAQ). About William A. Haseltine
Mr. Haseltine is well known for his pioneering work on cancer and HIV/AIDS. He is the Founder of Human Genome Sciences, Inc. and served as the Chairman and CEO of the Company until 2004. He is also the founder of seven other successful biotechnology companies. He serves as an advisor to CMEA, a venture capital company, and to several biotechnology and pharmaceutical companies.
William A. Haseltine PhD is Chairman of Haseltine Global Health, LLC, a virtual pharmaceutical company dedicated to developing new and more efficient means to create new life saving drugs and medical devices. He is also President of the Haseltine Foundation for Medical Sciences and the Arts, a foundation that supports access to high quality health for the poor and middle class of developing countries and that also fosters a dialog between sciences and the arts. He is an Adjunct Professor at The Scripps Institute for Medical Research. William Haseltine has an active career in both Science and Business. He was a professor at Harvard Medical School from 1976-1993 where he was the chair of two academic research departments. Dr. Haseltine is active in public service. He is Co-Chair of the President’s Council of the Cold Spring Harbor Laboratory, a member of the Advisory Board of the Global Coalition on HIV/AIDS, a member of the Board of One World Health, a member of the CEO Council of the New York Academy of Science, and Chair of the Berkeley Center of Synthetic Biology. He is a member of the Executive Committee of the Brookings Institution, a member of both the Council on Foreign Relations and the Trilateral Commission, and a member of the Chairman’s Circle of the Asia Society.
To learn more about the investor growth conference please visit the official invitation located online at http://www.smhib.com/events/IGC2006invitation.htm .
About Sanders Morris Harris Investment Banking
Sanders Morris Harris Investment Banking (http://www.smhib.com ) is headquartered in New York with regional offices in Los Angeles and Houston. The firm is a full-service investment bank providing middle-market companies with private placements and public offerings of equity and debt securities, as well as financial-advisory services in connection with mergers and acquisitions, restructuring and recapitalizations. Sanders Morris Harris Inc. is led with the same entrepreneurial spirit as the firm’s clients, and offers all of the advantages of a full-service, middle-market investment firm delivered by experienced senior bankers to optimally serve clients.
About Sanders Morris Harris Group
Sanders Morris Harris Group is a financial services holding company headquartered in Houston that manages more than $11.2 billion in client assets. It is the largest investment banking firm headquartered in the Southwest and provides a full range of asset and wealth management services and investment banking services including underwriting of private placements and public offerings of equity and debt securities, as well as financial advisory services. It also offers institutional equity sales, trading, and research, as well as prime brokerage services for hedge funds and fixed income securities sales and trading. Its operating entities are Sanders Morris Harris, Charlotte Capital, Kissinger Financial Services, Salient Partners, Salient Trust Co. LTA, SMH Capital Advisors, Select Sports Group, and The Edelman Financial Center. Sanders Morris Harris Group has 600 employees in 21 states. Additional information is available at http://www.smhgroup.com .
The conference is intended to allow investors to see and receive information directly from and ask questions of management of the presenter companies. Sanders Morris Harris does not review and disclaims any responsibility for any statements, opinions, or presentations made at the conference or any material provided by any presenter company. The information provided and opinions expressed at the conference are not intended to be a forecast of future events, a guarantee of future results, or investment advice and should not be relied on as such. This press release is not an offer to buy or sell any security. Sanders Morris Harris may have positions or make markets in, and it and its directors, officers, and employees may purchase, sell, or own securities of presenter companies and enter into transactions contrary to any opinion or information expressed at the conference. Mr. Haseltine is not an employee of or affiliated with Sanders Morris Harris. The opinions expressed by Mr. Haseltine are solely his own and do not necessarily reflect those of Sanders Morris Harris. Sanders Morris Harris Inc., its affiliates, and employees are not in the business of providing legal or tax advice. Investments and services are offered through Sanders Morris Harris Inc., member NASD/SIPC.
Contact: Amy Gottenberg Vice President, Marketing Sanders Morris Harris Group Inc. (212) 508-4003 amy.gottenberg@smhgroup.com Morris Harris Investment Banking
Sanders
CONTACT: Amy Gottenberg, Vice President, Marketing of Sanders MorrisHarris Group Inc., +1-212-508-4003, or amy.gottenberg@smhgroup.com
